Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHAR0002 > Drug Discovery In The Past & Personalised Medicine > Flashcards

Drug Discovery In The Past & Personalised Medicine Flashcards

1
Q

What medical treatments were previously discovered in nature (based on observation)? (4)

A
  1. Willow bark tea
  2. Fox glove tea
  3. Cow pox inoculations
  4. Chinese traditional medicine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What was willow bark tea used as a medicine for?

A

Pain & rheumatism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What was fox glove tea used as a medicine for?

A

Heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What were cow pox inoculations used as a medicine for?

A

Small pox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What was morphine extracted from and what was it used for?

A

Extracted from the opium poppy

Used as a painkiller

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What was digoxin extracted from and what is it used in?

A

Extracted from foxglove

Useful in the treatment of heart conditions (heart failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the limitation of traditional remedies, and how have improvements been made?

A

Mixtures of impure active compounds at variable and unknown concentrations

Improvements made by extracting active compounds from traditional remedies, purifying it, and giving it in a controlled concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are 2 examples of drugs from natural compounds?

A

Morphine

Digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What drug is an examples of chance identification? And who discovered it?

A

Penicillin

Discovered by Sir Alexander Fleming - he noticed that in one culture contaminated by mould, colonies closer to the mould had stopped growing, but those further away were growing properly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between arsanilic acid and (discovered) Salvarsan (606) in the treatment of syphylis ?

A

Arsanilic acid - kills syphylis-causing bacteria but is very toxic for humans
Salvarsan (606) - kills syphylis-causing bacteria but at a much lower concentration - therefore less toxic to humans - therapeutic window is wide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the idea of precision medicine?

A

Idea that if we could stratify patients based on predicted response to the drug, we could choose drugs that are most effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Studies have shown that variation in drug response is mainly determined by…

A

Genes (~inherited characteristics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is ‘pharmacogenetics’?

A

The study of variation in drug responses due to genetic variation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are 2 genetic polymorphisms leading to variation in drug response?

A
  1. Pharmacokinetic differences in drug-metabolising enzymes and drug transporters - leads to variation in the concentration of the drug at the target
  2. Pharmacodynamic differences in drug target or downstream signalling effectors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How could patient genotyping improve dose selection?

A

To understand the pharmacokinetic differences - variation in genes that encode drug-metabolising enzymes & drug transporters which leads to variation in the concentration of the drug at the target

Determining the genotype of the patient would allow us to calculate the dose of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How could patient genotyping improve drug selection?

A

Pharmacodynamic differences - genetic variation in genes encoding particular drug targets / proteins or downstream signalling effectors

Patient genotyping could better inform the decision on which drug to use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is Suxamethonium and how does it work?

A

DNC neuromuscular blocker
Skeletal muscle relaxant

Binds to ACh receptor on neuromuscular junctions and causes prolonged depolarisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the impact of patients having butyrylcholinesterase (BChE) polymorphism?

A

Suxamethonium is normally inactivated by BCHE enzyme in approx 10 mins

However, some patients have mutation in this enzyme, and in homozygous variation, this mutation causes dramatic reduction in enzyme activity - takes up to 10 hours

  • Scoline apnoea?

To avoid this effect, patients are genotyped before Suxamethonium is given

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are statins used for?

A

Given to many patients to decrease the risk of cardiovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Some genetic variants in transporter gene increase the risk of…

A

Statin-induced myopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is statin-induced myopathy?

A

Statin-induced myopathy is a potential side effect of statin medications, which are commonly prescribed to lower cholesterol levels and reduce the risk of heart disease.

Myopathy refers to muscle damage or weakness/

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are SNPs?

A

Single nucleotide polymorphisms

(Smallest unit of genetic variation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What was discovered in the study of statin-induced myopathy and transporter polymorphism?

A

SNP in OATP transporter gene was found to be very highly associated with myopathy

The OATP transporter was shown to be involved in the uptake of statins into the liver for metabolism
So having this particular SNP greatly increased the risk of developing myopathy upon treatment with statins

Therefore treatment with statins could be made more safe if patient genotype was determined first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What was the process of the study of statin-induced myopathy and transporter polymorphism?

A

Clinical trial
6000 patients given statins - 85 developed myopathy, 90 controls selected (who had not developed myopathy)
6000 patients given placebo

Genome wide association study
>300,000 SNPs determined for each of the 85 test subjects and 90 controlled
Association with myopathy was calculated (y axis on graph)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is an example of genetic polymorphism in the target gene?

A

HER2 in breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is over-expressed in ~ 20% of breast cancer patients?

A

HER2 receptor tyrosine kinase

27
Q

What does over-expression of HER2 in breast cancer cause?

A

Anti-apoptosis
Cell proliferation

28
Q

What is Trastuzumab?

A

A monoclonal antibody against HER2
Effective drug in treatment of breast cancer patients with an over-expression of HER2

29
Q

What does the (monoclonal antibody) Trastuzumab do in the treatment of breast cancer

A

Monoclonal antibody (Trastuzumab) binds to HER2 (RTK) - triggers immune response & prevents dimerisation (activation) of HER2 (RTK) which prevents proliferation and causes apoptosis

30
Q

What technique can be used to select patients for Trastuzumab treatment?

A

Molecular typing of tumour

Small fragment of tissue removed from the body and analysed - HER2 comes up as brown, blue is cell nuclei - can see the level of expression of HER2

With a higher expression of HER2, the patient will benefit more than others from monoclonal antibody treatment (Trastuzumab)

31
Q

HER2 RTK over-expression is found in which cancer patients?

A

In ~20% breast cancer patients
In ~20% stomach cancer patients
In a small proportion of oesophagus cancer patients

32
Q

How can ‘liquid biopsies’ be used in the choice of precision medicines?

A

Liquid biopsies - small blood sample can be analysed for identifying cell fragments & nucleic acids shed into circulation by dying cancer cells

This can be used to identify components which characterise the cancer to better choose precision medicines

33
Q

What two things can be used in the development of precision medicines for cancer?

A

Molecular characterisation (rather than anatomy / histology)
Molecular typing of tumour to identify the most effective treatment

34
Q

What is cystic fibrosis and what is it caused by?

A

Cystic fibrosis is a common genetic disease

It is caused by mutations in the CFTR gene, which encodes the Cl- channel in apical membrane in airway and other epithelia (e.g. in intestine)

35
Q

What are the 2 most common Cystic fibrosis-causing mutations?

A

△F508: >90% patients
G551D: <5% patients

36
Q

What is the effect the G551D mutation (polymorphism) in cystic fibrosis?

A

G551D mutation causes defective gating in the CFTR protein which regulates the movement of chloride ions (Cl-) across cell membranes

G551D mutation means that CFTR mostly stays in the closed gate conformation. This leads to a build-up of Cl- ions in cells & tissues, which can lead to the formation of thick, sticky mucus that clogs the airways and causes respiratory problems (hallmark of CF)

37
Q

What is the effect of the △F508 mutation of CFTR in cystic fibrosis?

A

Defective folding
- folding is inefficient so over 99% of the translated protein is degraded - reducing the amount of functional CFTR protein at the cell membrane - contributing to symptoms of CF

38
Q

What is the precision medicine treatment strategy for cystic fibrosis patients carrying the G551D mutation of CFTR?

A

CFTR modulator

potentiator - keeps the gate of the CFTR open

Example - VX-770 (kalydeco) - causes increased lung function & dramatic improvement of health

However, this drug is ineffective in △F508-carrying patients

39
Q

What is the precision medicine strategy for cystic fibrosis patients carrying the △F508 mutation that gives a moderate effect?

A

Combining treatments:
VX-770 + VX-809 (Orkambi)

But only gave a small improvement in lung function, reduced degradation of protein

40
Q

What is the effective precision medicine strategy for cystic fibrosis patients carrying the △F508 mutation?

A

Trikafta:

VX-770 + VX-661 + VX-445

Causes major improvement of lung function: is a combination of 2 correctors (act on the folding) and a potentiator (keeps the gate open)

41
Q

What are pharmacogenomics?

A

How variation in the whole genome affects the response to drugs

42
Q

What is the idea of ‘theradiagnostics’?

A

Therapy + diagnosis

The idea is to combine these 2 elements so that the treatment is more tailored to the individual

43
Q

What is an example of ‘theradiagnostics’?

A

Targeted radionucleotide therapy for acute leukaemia

44
Q

How does targeted nucleotide therapy for acute leukaemia work?

A

Targets moiety (specific fragment of a molecule) by using:

Anti-CD66 monoclonal antibody (that recognises tumour cells) coupled to a diagnostic and a therapeutic radionucleotide

45
Q

What is the role of the diagnostic radionucleotide (111ln) in targeted radionucleotide therapy for acute leukaemia?

A
  • suitable for non-invasive imaging
  • can be used to identify whether patients benefit from the therapy, as using the same target allows us to see where the radioactive nucleotide would be delivered
  • can be used to calculate the ideal dose of radiotherapy
  • can be used to assess the efficacy of the radiotherapy post-session
46
Q

What is the role of the therapeutic radionucleotide (90Y) in targeted radionucleotide therapy for acute leukaemia?

A
  • suitable for irradiation of cancer cells (to kill the cancer cells)
47
Q

How does (personalised treatment) CAR-T work to treat blood cancers?

A
  1. Apheresis - patient’s T-cells (immune cells) isolated and collected from the body
  2. T-cells genetically modified to express chimeric antigen receptors (CAR) which can recognise and specifically kill cancer cells - become CAR-T cells
  3. Cells multiplied
  4. Cells infused back into blood circulation through IV
  5. CAR-T cells kill cancer cells
  6. Release of cytokines - to promote future killing of cancer cells
48
Q

What are advantages and disadvantages of CAR-T treatment of blood cancers?

A

+ has been successful in some treatment of leukaemias

  • however, can also have some very serious side effects (e.g. attacking non-cancerous cells)
  • has lead to the development of resistant cancers (in some cases)
49
Q

What is the purpose of Structure Activity Relationship (SAR) studies?

A

To compare and find the compound with the best characteristics

50
Q

What did Sir James Black hypothesise and why?

A

Was studying angina - oxygen delivery to the heart is insufficient
Was studying adrenaline & noradrenaline, knew that adrenaline inc O2 requirement for the heart
Therefore hypothesised that if he could block adrenaline receptors, the situation could be improved

51
Q

What was the first B-blocker to be used?

A

Propranolol (beta-antagonist)

52
Q

What does Isoprenaline act as?

A

Full agonist of beta-adrenoreceptors in the heart

53
Q

What does Dichloproisoprenaline act as?

A

Partial agonist of the beta-adrenoceptors in the heart

54
Q

What does Propanolol act as?

A

Antagonist of beta-adrenoceptors

55
Q

What did Sir James Black do in his Structure Activity Relationship study of isoprenaline and dichloroisoprenaline

A

After synthetic modification, produced propanolol - antagonist of beta-adrenoceptors

56
Q

What is propanolol used to treat?

A

Hypertension, angina and other cardiovascular conditions

57
Q

What did Paul Erlich & Alfred Bertheim do in their structure activity relationship study (SAR) ?

A

Synthesised over 600 derivatives of arsanilic acid

Found Salvarsan (606)

58
Q

What are the 2 main steps in modern drug development?

A
  1. Target and lead compound (compound that acts on the target and has a desired effect) identification
  2. Lead compound optimisation
59
Q

How is the drug target identified in drug development?

A

Usually proteins - surface receptors, enzymes, structural proteins

Mostly identified due to our understanding of basic mechanisms underlying disease

60
Q

How is the lead compound (compound that acts on the target and has a desired effect) identified in drug development?

A

Biological intelligence
High-throughput screening

61
Q

What are the 3 ways of lead compound optimisation?

A
  1. Increase potency
  2. Improve pharmacokinetics - how the drug is handled in the body; how it is distributed, metabolised & eliminated
  3. Minimised unwanted effects (toxicity)
62
Q

What is the importance of lead identification in rational drug design?

A

If the structure of the target protein is known, chemical can be designed & optimised in silico

63
Q

What is the drug target for thrombocytopaenia (low platelet count in blood)

A

Thrombopoietin (TPO) receptor

PHAR0002 (20 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions